These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 20109651)

  • 81. Which is the preferred blood product for fibrinogen replacement in the bleeding patient with acquired hypofibrinogenemia-cryoprecipitate or fibrinogen concentrate?
    Cushing MM; Haas T; Karkouti K; Callum J
    Transfusion; 2020 Jun; 60 Suppl 3():S17-S23. PubMed ID: 32478877
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Hypodysfibrinogenemia during pregnancy, labor, and delivery.
    Deering SH; Landy HJ; Tchabo N; Kessler C
    Obstet Gynecol; 2003 May; 101(5 Pt 2):1092-4. PubMed ID: 12738112
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Women With Congenital Hypofibrinogenemia/Afibrinogenemia: From Birth to Death.
    Zhang Y; Zuo X; Teng Y
    Clin Appl Thromb Hemost; 2020; 26():1076029620912819. PubMed ID: 32233805
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients.
    Abrahamyan L; Tomlinson G; Callum J; Carcone S; Grewal D; Bartoszko J; Krahn M; Karkouti K
    JAMA Surg; 2023 Mar; 158(3):245-253. PubMed ID: 36598773
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism.
    Martinez J; Holburn RR; Shapiro SS; Erslev AJ
    J Clin Invest; 1974 Feb; 53(2):600-11. PubMed ID: 11344575
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cryoprecipitate as a reliable source of fibrinogen replacement.
    Ness PM; Perkins HA
    JAMA; 1979 Apr; 241(16):1690-1. PubMed ID: 430729
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Novel fibrinogen mutation (gamma 313 Ser-->Asn) associated with hypofibrinogenemia in two unrelated families.
    Meyer M; Bergmann F; Brennan SO
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):63-7. PubMed ID: 16607083
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prospective, Randomized Study of Fibrinogen Concentrate Versus Cryoprecipitate for Correcting Hypofibrinogenemia in Cardiac Surgery Patients.
    Ayaganov D; Kuanyshbek A; Vakhrushev I; Li T
    J Cardiothorac Vasc Anesth; 2024 Jan; 38(1):80-85. PubMed ID: 38016817
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Fibrinogen Seoul (FGG Ala341Asp): a novel mutation associated with hypodysfibrinogenemia.
    Song KS; Park NJ; Choi JR; Doh HJ; Chung KH
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):338-43. PubMed ID: 16959688
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prophylactic cryoprecipitate in congenital afibrinogenemia.
    Rodriguez RC; Buchanan GR; Clanton MS
    Clin Pediatr (Phila); 1988 Nov; 27(11):543-5. PubMed ID: 3180628
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The cryoprecipitate: that old unknown.
    Blasi A; Beltran J; Pereira A; Puig L
    Rev Esp Anestesiol Reanim; 2015 Apr; 62(4):204-12. PubMed ID: 25561426
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Perioperative factor concentrate therapy.
    Tanaka KA; Esper S; Bolliger D
    Br J Anaesth; 2013 Dec; 111 Suppl 1():i35-49. PubMed ID: 24335398
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The efficacy and safety of cryoprecipitate in the treatment of acquired hypofibrinogenaemia.
    Idris SF; Hadjinicolaou AV; Sweeney M; Winthrop C; Balendran G; Besser M
    Br J Haematol; 2014 Aug; 166(3):458-61. PubMed ID: 24725203
    [No Abstract]   [Full Text] [Related]  

  • 94. Heterozygous FGA p.Asp473Ter (fibrinogen Nieuwegein) presenting as antepartum cerebral thrombosis.
    Tajdar M; Orlando C; Casini A; Herpol M; De Bisschop B; Govaert P; Neerman-Arbez M; Jochmans K
    Thromb Res; 2018 Mar; 163():185-189. PubMed ID: 29122299
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Novel homozygous fibrinogen Aα chain truncation causes severe afibrinogenemia with life threatening complications in a two-year-old boy.
    Stikarová J; Blatný J; Kotlín R; Suttnar J; Zapletal O; Pimková K; Májek P; Hrachovinová I; Dyr JE
    Thromb Res; 2013 Oct; 132(4):490-2. PubMed ID: 24050829
    [No Abstract]   [Full Text] [Related]  

  • 96. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage.
    Bell SF; Rayment R; Collins PW; Collis RE
    Int J Obstet Anesth; 2010 Apr; 19(2):218-23. PubMed ID: 20194010
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Hypodysfibrinogenemia: fibrinogen giessen II (author's transl)].
    Krause WH; Huth K; Heene DL; Lasch HG
    Klin Wochenschr; 1975 Aug; 53(16):781-2. PubMed ID: 1165625
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Congenital hypofibrinogenemia in pregnancy: report of two cases and review of the literature.
    Frenkel E; Duksin C; Herman A; Sherman DJ
    Obstet Gynecol Surv; 2004 Nov; 59(11):775-9. PubMed ID: 15502629
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Fibrinogen giessen I: a congenital homozygously expressed dysfibrinogenemia with A alpha 16 Arg----His substitution.
    Alving BM; Henschen AH
    Am J Hematol; 1987 Aug; 25(4):479-82. PubMed ID: 3618591
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Surgical wound healing in bleeding disorders.
    Rodriguez-Merchan EC
    Haemophilia; 2012 Jul; 18(4):487-90. PubMed ID: 22335628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.